Search Weight Loss Topics:




Oct 16

Novo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss … – Investopedia

Lose Weight Comments Off on Novo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss … – Investopedia

Key Takeaways

Novo Nordisk (NVO) boosted its guidance for the second time in two months as demand soars for its diabetes treatments, Ozempic and Wegovy. American depositary receipts (ADRs) of Novo Nordisk rose close to 2% to an all-time high on Friday following the news.

The Danish drugmaker now predicts full-year sales will increase 32% to 38%, up from its previous forecast of a gain of 27% to 33%. It anticipates operating profit growth of 40% to 46% versus its earlier estimate of 31% to 37%.

Novo Nordisk noted that the change was primarily reflected in higher expectations for Ozempic volumes in the U.S., and gross-to-net sales adjustments for Ozemic and Wegovy in the U.S.

For the third quarter and first nine months of the year, Novo Nordisk expects revenue growth of 38% and 33%, respectively. Operating profit expansion over the same periods are projected at 47% and 37%, respectively. Those results are scheduled to be released Nov. 2.

The success of Ozempic and Wegovy in helping patients lose weight has led to a boom in demand. In August, the company reported sales of its treatments skyrocketed 158% in the first six months of the year.

Ozempic and Wegovy are being tested for other uses as well. Earlier this week, Novo Nordisk reported it had halted a trial of Ozempic to treat chronic kidney disease early because preliminary results showed signs of success. Two months ago, it released results of a study that indicated Wegovy was successful in reducing major adverse cardiovascular events in patients with cardiovascular disease.

TradingView

See the rest here:
Novo Nordisk Boosts Its Guidance on Demand for Its Weight-Loss ... - Investopedia

Related Posts

    Your Full Name

    Your Email

    Your Phone Number

    Select your age (30+ only)

    Select Your US State

    Program Choice

    Confirm over 30 years old

    Yes

    Confirm that you resident in USA

    Yes

    This is a Serious Inquiry

    Yes

    Message:



    matomo tracker